Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 HKD | 0.00% | +4.52% | -48.47% |
Apr. 30 | Transcenta Holding Limited Announces Board and Nomination Changes | CI |
Apr. 09 | Transcenta Partners with Agilent to Develop Claudin18.2 Companion Diagnostic | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | - | 1,150 | 1,359 | 696.7 | - | - |
Enterprise Value (EV) 1 | - | 665.7 | 1,173 | 919.1 | 241.3 | 716.7 |
P/E ratio | - | -2.91 x | -2.86 x | -2.26 x | -1.57 x | -1.45 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | 11.3 x | 25.2 x | 4.32 x | 3.95 x | 9.13 x |
EV / Revenue | - | 6.53 x | 21.8 x | 5.69 x | 1.37 x | 9.39 x |
EV / EBITDA | - | -1.67 x | -2.65 x | -3.3 x | -0.65 x | -1.56 x |
EV / FCF | - | -2.09 x | - | -0.95 x | -0.44 x | -1.81 x |
FCF Yield | - | -47.8% | - | -105% | -227% | -55.3% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | - | 419,920 | 416,576 | 405,965 | - | - |
Reference price 2 | 7.496 | 2.738 | 3.263 | 1.716 | 1.716 | 1.716 |
Announcement Date | 3/21/22 | 3/30/23 | 3/27/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | 50.24 | 101.9 | 53.85 | 161.4 | 176.3 | 76.29 |
EBITDA 1 | -434.4 | -398.5 | -442.1 | -278.9 | -369.2 | -459.8 |
EBIT 1 | -480.2 | -442.3 | -485 | -323.7 | -455.3 | -437.6 |
Operating Margin | -955.81% | -434.13% | -900.75% | -200.54% | -258.3% | -573.63% |
Earnings before Tax (EBT) 1 | - | -407 | -462.8 | -308.6 | -457.4 | -437.8 |
Net income 1 | - | -406.7 | -462.6 | -308.6 | -457.4 | -480.5 |
Net margin | - | -399.19% | -859.01% | -191.18% | -259.5% | -629.82% |
EPS 2 | - | -0.9400 | -1.140 | -0.7600 | -1.095 | -1.180 |
Free Cash Flow 1 | - | -318 | - | -964 | -547 | -396 |
FCF margin | - | -312.09% | - | -597.15% | -310.32% | -519.05% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - |
Announcement Date | 3/21/22 | 3/30/23 | 3/27/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|
Net sales 1 | 23.56 | - | 80.13 | 36.08 | 17.76 | 26.66 | 134.8 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | -275.6 | - | -216.2 | -255.8 | -229.3 | -196.7 | -127.1 |
Operating Margin | -1,170.02% | - | -269.8% | -708.85% | -1,290.54% | -737.89% | -94.27% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - |
Net income | - | -204.1 | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - |
EPS 2 | - | -0.4700 | - | -0.5800 | -0.5600 | -0.4600 | -0.2900 |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 3/21/22 | 8/29/22 | 3/30/23 | 8/22/23 | 3/27/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 222 | - | 19.9 |
Net Cash position 1 | 857 | 484 | 186 | - | 455 | - |
Leverage (Debt/EBITDA) | - | - | - | -0.7972 x | - | -0.0434 x |
Free Cash Flow 1 | - | -318 | - | -964 | -547 | -396 |
ROE (net income / shareholders' equity) | - | -23.7% | -35% | -822% | - | - |
ROA (Net income/ Total Assets) | - | -17.4% | -32.1% | -15.8% | -9.4% | - |
Assets 1 | - | 2,340 | 1,440 | 1,953 | 4,866 | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - |
Capex 1 | - | 22.2 | - | 426 | 80 | 80 |
Capex / Sales | - | 21.77% | - | 263.88% | 45.38% | 104.86% |
Announcement Date | 3/21/22 | 3/30/23 | 3/27/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.47% | 96.31M | |
+38.00% | 705B | |
+32.82% | 583B | |
-3.69% | 364B | |
+20.10% | 332B | |
+4.91% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.74% | 169B |
- Stock Market
- Equities
- 6628 Stock
- Financials Transcenta Holding Limited